Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has completed a significant capital injection of RMB493.6 million into Tianjin Pharmaceutical Group Taiping Medicine Co., Ltd. This move, involving the transfer of full equity interest in Tianjin Zhongxin Medicine Co., Ltd., aims to strengthen its position in the pharmaceutical sector. The completion follows the resolutions passed during the company’s board meeting and subsequent approvals.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
